| Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy CH Ries, MA Cannarile, S Hoves, J Benz, K Wartha, V Runza, ... Cancer cell 25 (6), 846-859, 2014 | 1355 | 2014 |
| The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma KJ Savage, S Monti, JL Kutok, G Cattoretti, D Neuberg, L De Leval, ... Blood 102 (12), 3871-3879, 2003 | 1044 | 2003 |
| Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response S Monti, KJ Savage, JL Kutok, F Feuerhake, P Kurtin, M Mihm, B Wu, ... Blood 105 (5), 1851-1861, 2005 | 988 | 2005 |
| Targetable genetic features of primary testicular and primary central nervous system lymphomas B Chapuy, MGM Roemer, C Stewart, Y Tan, RP Abo, L Zhang, AJ Dunford, ... Blood, The Journal of the American Society of Hematology 127 (7), 869-881, 2016 | 543 | 2016 |
| High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma G Illerhaus, R Marks, G Ihorst, R Guttenberger, C Ostertag, G Derigs, ... Journal of clinical oncology 24 (24), 3865-3870, 2006 | 341 | 2006 |
| NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes F Feuerhake, JL Kutok, S Monti, W Chen, AS LaCasce, G Cattoretti, ... Blood 106 (4), 1392-1399, 2005 | 306 | 2005 |
| High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system G Illerhaus, F Müller, F Feuerhake, AO Schäfer, C Ostertag, J Finke Haematologica 93 (1), 147-148, 2008 | 229 | 2008 |
| Therapeutic interleukin-6 trans-signaling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease S Schreiber, K Aden, JP Bernardes, C Conrad, F Tran, H Höper, V Volk, ... Gastroenterology 160 (7), 2354-2366. e11, 2021 | 174 | 2021 |
| Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy J Klisch, F Juengling, J Spreer, D Koch, T Thiel, M Büchert, S Arnold, ... American journal of neuroradiology 22 (5), 824-830, 2001 | 169 | 2001 |
| Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas PS Zeiner, C Preusse, A Golebiewska, J Zinke, A Iriondo, A Muller, ... Brain pathology 29 (4), 513-529, 2019 | 144 | 2019 |
| High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study G Illerhaus, R Marks, F Müller, G Ihorst, F Feuerhake, M Deckert, ... Annals of oncology 20 (2), 319-325, 2009 | 135 | 2009 |
| Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness J Honegger, C Prettin, F Feuerhake, M Petrick, J Schulte-Mönting, ... Journal of neurosurgery 99 (4), 674-679, 2003 | 120 | 2003 |
| ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition PG Kemps, J Picarsic, BH Durham, Z Hélias-Rodzewicz, L Hiemcke-Jiwa, ... Blood, The Journal of the American Society of Hematology 139 (2), 256-280, 2022 | 96 | 2022 |
| Whither systems medicine? R Apweiler, T Beissbarth, MR Berthold, N Blüthgen, Y Burmeister, ... Experimental & molecular medicine 50 (3), e453-e453, 2018 | 77 | 2018 |
| Expression and prognostic value of L1-CAM in breast cancer C Schröder, U Schumacher, M Fogel, F Feuerhake, V Müller, RM Wirtz, ... Oncology reports 22 (5), 1109-1117, 2009 | 73 | 2009 |
| High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non–small-cell lung cancer K Gately, L Forde, S Cuffe, R Cummins, EW Kay, F Feuerhake, KJ O'Byrne Clinical lung cancer 15 (1), 58-66, 2014 | 71 | 2014 |
| Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib ME Halatsch, S Loew, K Mursch, T Hielscher, U Schmidt, A Unterberg, ... Journal of neurosurgery 111 (2), 211-218, 2009 | 67 | 2009 |
| Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium F Feuerhake, W Sigg, EA Höfter, T Dimpfl, U Welsch Cell and tissue research 299, 47-58, 2000 | 64 | 2000 |
| Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL F Feuerhake, B Volk, C Ostertag, F Jungling, J Kassubek, M Orszagh, ... Acta neuropathologica 103, 188-192, 2002 | 63 | 2002 |
| Expression of inducible cell adhesion molecules in the normal human lung: immunohistochemical study of their distribution in pulmonary blood vessels F Feuerhake, G Füchsl, R Bals, U Welsch Histochemistry and cell biology 110 (4), 387-394, 1998 | 62 | 1998 |
